The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year

1988

Stage

Acquired | Acquired

Total Raised

$4.1M

About Genica Pharmaceuticals

Operator of a reference laboratory dedicated to the development and commercialization of diagnostics and therapeutics for neurological and neurogenetic disorders. Genica offers an extensive selection of testing services and interpretive consultation. The full-service neurology laboratory offers Southern blot, PCR, PFGE, Western blot, biochemical, and ELISA methodologies. The company provides novel, proprietary tests for neurological disorders in nine major areas. For neurological autoimmune diseases, the MAG and GM1 autoantibody tests were introduced to physicians in 1990. In February 1991, Genica began offering autoantibody tests for paraneoplastic syndrome with technology licensed from Sloan-Kettering Cancer Center. In addition to neurogenetic disorders and autoimmune association with peripheral nerve diseases, the company provides state-of-the-art technology for neurological complications of Lyme disease, testing services for the neuromuscular transmission defect known as Myasthenia Gravis and offers the world's first commercially available risk-factor diagnostic for Alzheimer's disease.

Genica Pharmaceuticals Headquarter Location

377 Plantation Street Four Biotech Park

Worcester, Massachusetts, 01605,

United States

(508)756-2886

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • When was Genica Pharmaceuticals founded?

    Genica Pharmaceuticals was founded in 1988.

  • Where is Genica Pharmaceuticals's headquarters?

    Genica Pharmaceuticals's headquarters is located at 377 Plantation Street, Worcester.

  • What is Genica Pharmaceuticals's latest funding round?

    Genica Pharmaceuticals's latest funding round is Acquired.

  • How much did Genica Pharmaceuticals raise?

    Genica Pharmaceuticals raised a total of $4.1M.

  • Who are the investors of Genica Pharmaceuticals?

    Investors of Genica Pharmaceuticals include Aetna, MVP, Oxford Partners and Venca.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.